Last €68.97 EUR
Change Today -0.28 / -0.40%
Volume 240.9K
UCB On Other Exchanges
Symbol
Exchange
EN Brussels
OTC US
OTC US
Frankfurt
As of 11:35 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ismail Kola Ph.D.

Chief Scientific Officer, Executive Vice President and Head of New Medicines™, UCB S.A.
AgeTotal Calculated CompensationThis person is connected to 69 board members in 6 different organizations across 8 different industries.

See Board Relationships
57--

Background*

Dr. Ismail Kola, Ph.D. has been the Chief Scientific Officer and Head of New Medicines™ at UCB S.A. since January 2015 and serves as its Executive Vice President. Dr. Kola served as President of UCB New Medicines(TM) for UCB SA since November 23, 2009. Dr. Kola served as the President of UCB NewMedicines at Kremers Urban Pharmaceuticals Inc. He served as Executive Vice President of Ucb Newmedicines (TM) at Ucb S.A. He served as an Executive Vice President of UCB SA since ...

Read Full Background

Corporate Headquarters*

Allée de la Recherche, 60
Brussels, Brussels 1070

Belgium

Phone: 32 2 559 99 99
Fax: 32 2 559 99 00

Board Members Memberships*

Non Executive Director
2010-Present
Director and Member of Nominations & Corporate Governance Committee
2010-Present
Director
2010-Present
Director
2011-Present
Director and Member of Governance & Nominating Committee
2011-Present
Director and Member of Nomination & Remuneration Committee

Education*

PhD
University of Cape Town
BS
University of South Africa

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UCB:BB €68.97 EUR -0.28

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UCB SA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.